Yüksel, A. et al. 2026. Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD). Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 43, 1 (Mar. 2026), 17022. DOI:https://doi.org/10.36141/svdld.2026.17022.